Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


Vitae Pharmaceuticals, Inc.

Statements of Comprehensive Income

 
  Year Ended December 31,  
 
  2013   2012  

Net income

  $ 1,161,898   $ 223,086  

Other comprehensive income (loss):

             

Unrealized (losses) gains on marketable securities

    (2,906 )   5,859  
           

Comprehensive income

  $ 1,158,992   $ 228,945  
           
           

   

The accompanying notes are an integral part of these financial statements.

F-5